Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders

References

• PerlisRHPharmacogenomic testing and personalized treatment of depressionClin Chem2014601535924281779
   PubMed Web of Science ®Google Scholar
• SamerCFLorenziniKIRollasonVDaaliYDesmeulesJAApplications of CYP450 testing in the clinical settingMol Diagn Ther201317316518423588782
   PubMed Web of Science ®Google Scholar
• MrazekDAPsychiatric pharmacogenomic testing in clinical practiceDialogues Clin Neurosci2010121697620373668
   PubMedGoogle Scholar
• MurphyGMKremerCRodriguesHESchatzbergAFPharmacogenetics of antidepressant medication intoleranceAm J Psychiatry2003160101830183514514498
   PubMed Web of Science ®Google Scholar
• KielingCGenroJPHutzMHRohdeLAA current update on ADHD pharmacogenomicsPharmacogenomics201011340741920235795
   PubMed Web of Science ®Google Scholar
• HicksJKBishopJRSangkuhlKClinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitorsClin Pharmacol Ther201598212713425974703
   PubMed Web of Science ®Google Scholar
• BishopJRNajjarFRubinLHEscitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorderPharmacogenet Genomics2015251154855426313485
   PubMed Web of Science ®Google Scholar
• StevensADe LeonibusCHansonDPediatric perspective on pharmacogenomicsPharmacogenomics201314151889190524236488
   PubMed Web of Science ®Google Scholar
• GazouliMPachoulaIPanayotouIThiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel diseaseAnn Gastroenterol201225324925324714152
   PubMedGoogle Scholar
• WuXTHuFYAnDMAssociation between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central ChinaEpilepsy Behav201019340540820833111
   PubMed Web of Science ®Google Scholar
• SmithTSharpSManzardoAMButlerMGPharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case reportInt J Mol Sci20151634416442825710722
   PubMed Web of Science ®Google Scholar
• KronenbergSApterABrentDSerotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disordersJ Child Adolesc Psychopharmacol200717674175018315446
   PubMed Web of Science ®Google Scholar
• BowersKLinPIEricksonCPharmacogenomic medicine in autism: challenges and opportunitiesPaediatr Drugs201517211512425420674
   PubMed Web of Science ®Google Scholar
• ChristensenDLBaioJBraunKVPrevalence and characteristics of autism spectrum disorder among children aged 8 years – autism and developmental disabilities monitoring network, 11 sites, United States, 2012MMWR Surveill Summ2016653123
   PubMed Web of Science ®Google Scholar
• LeyferOTFolsteinSEBacalmanSComorbid psychiatric disorders in children with autism: interview development and rates of disordersJ Autism Dev Disord200636784986116845581
   PubMed Web of Science ®Google Scholar
• VolkmarFSiegelMWoodbury-smithMKingBMcCrackenJStateMPractice parameter for the assessment and treatment of children and adolescents with autism spectrum disorderJ Am Acad Child Adolesc Psychiatry201453223725724472258
   PubMed Web of Science ®Google Scholar
• AchenbachTMMcconaughySHHowellCTChild/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificityPsychol Bull198710122132323562706
   PubMed Web of Science ®Google Scholar
• PoseyDJStiglerKAEricksonCAMcDougleCJAntipsychotics in the treatment of autismJ Clin Invest2008118161418172517
   PubMed Web of Science ®Google Scholar
• ØienRAHartLSchjølbergSParent-endorsed sex differences in toddlers with and without ASD: utilizing the M-CHATJ Autism Dev Disord201747112613427757737
   PubMed Web of Science ®Google Scholar
• HepburnSLSternJABlakeley-SmithAKimelLKReavenJAComplex psychiatric comorbidity of treatment-seeking youth with autism spectrum disorder and anxiety symptomsJ Ment Health Res Intellect Disabil20147435937825960821
   PubMed Web of Science ®Google Scholar
• ZitoJSaferDJLolkjeTWA three-country comparison of psychotropic medication prevalence in youthChild Adolesc Psychiatry Ment Health2008212618817536
   PubMedGoogle Scholar
• SooryaLKiarashiJHollanderEPsychopharmacologic interventions for repetitive behaviors in autism spectrum disordersChild Adolesc Psychiatr Clin N Am200817475377118775368
   PubMed Web of Science ®Google Scholar
• RosenbergREMandellDSFarmerJELawJKMarvinARLawPAPsychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007–2008J Autism Dev Disord201040334235119806445
   PubMed Web of Science ®Google Scholar
• ReavenJBlakeley-SmithACulhane-ShelburneKHepburnSGroup cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: a randomized trialJ Child Psychol Psychiatry201253441041922435114
   PubMed Web of Science ®Google Scholar
• StorchEAArnoldEBLewinABThe effect of cognitive-behavioral therapy versus treatment as usual for anxiety in children with autism spectrum disorders: a randomized, controlled trialJ Am Acad Child Adolesc Psychiatry201352213214223357440
   PubMed Web of Science ®Google Scholar
• McDougleCJKreschLEPoseyDJRepetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitorsJ Autism Dev Disord200030542743511098879
   PubMed Web of Science ®Google Scholar
• Van CleaveJLeTTPerrinJMPoint-of-care child psychiatry expertise: the Massachusetts Child Psychiatry Access ProjectPediatrics2015135583484125896844
   PubMed Web of Science ®Google Scholar
• KennardBDSilvaSGTonevSRemission and recovery in the treatment for adolescents with depression study (TADS): acute and long-term outcomesJ Am Acad Child Adolesc Psychiatry200948218619519127172
   PubMed Web of Science ®Google Scholar
• BaldwinDGeneralized anxiety disorderEncyclopedia of PsychopharmacologyBerlin, HeidelbergSpringer2010551553
   Google Scholar
• BaribeauDAAnagnostouEAn update on medication management of behavioral disorders in autismCurr Psychiatry Rep201416343724488702
   PubMed Web of Science ®Google Scholar
• JohncoCJDe NadaiASLewinABEhrenreich-MayJWoodJJStorchEADefining treatment response and symptom remission for anxiety disorders in pediatric autism spectrum disorders using the Pediatric Anxiety Rating ScaleJ Autism Dev Disord201545103232324226031924
   PubMed Web of Science ®Google Scholar
• CouryDLAnagnostouEManning-courtneyPUse of psychotropic medication in children and adolescents with autism spectrum disordersPediatrics2012130Suppl 2S69S7623118256
   PubMed Web of Science ®Google Scholar
• SchneiderCTaylorDZalsmanGFrangouSKyriakopoulosMAntipsychotics use in children and adolescents: an on-going challenge in clinical practiceJ Psychopharmacol201428761562324902872
   PubMed Web of Science ®Google Scholar
• WolraichMBrownLBrownRTADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsPediatrics201112851007102222003063
   PubMed Web of Science ®Google Scholar
• Autism SpeaksWhat is autism?2015 Available from: http://www.autismspeaks.org/what-autismAccessed May 13, 2017
   Google Scholar
• CheungAHZuckerbrotRAJensenPSGhalibKLaraqueDSteinREKGuidelines for adolescent depression in primary care (GLAD-PC): II. Treatment and ongoing managementPediatrics20071205e1313e132617974724
   PubMed Web of Science ®Google Scholar
• Centers for Medicare and Medicaid ServicesAtypical antipsychotic medications: use in pediatric patients2013 Available from: https://www.cms.gov/medicare-medicaid-coordination/fraud-prevention/medicaid-integrity-education/pharmacy-education-materials/downloads/atyp-antipsych-pediatric-factsheet.pdfAccessed May 13, 2017
   Google Scholar
• AmanMGLamKSVan bourgondienMEMedication patterns in patients with autism: temporal, regional, and demographic influencesJ Child Adolesc Psychopharmacol200515111612615741793
   PubMed Web of Science ®Google Scholar
• WinkLKPedapatiEVHornPSMcDougleCJEricksonCAMultiple antipsychotic medication use in autism spectrum disorderJ Child Adolesc Psychopharmacol2017271919426465194
   PubMed Web of Science ®Google Scholar
• GargPLillystoneDDossetorDA framework for developing a curriculum regarding autism spectrum disorders for primary care providersJ Clin Diagn Res2015910SC01SC06
   Google Scholar
• CarbonePSBehlDDAzorVMurphyNAThe medical home for children with autism spectrum disorders: parent and pediatrician perspectivesJ Autism Dev Disord20104031732419768528
   PubMed Web of Science ®Google Scholar
• ThomasCRHolzerCEThe continuing shortage of child and adolescent psychiatristsJ Am Acad Child Adolesc Psychiatry20064591023103116840879
   PubMed Web of Science ®Google Scholar
• FarmerJEClarkMJMayfieldWAThe relationship between the medical home and unmet needs for children with autism spectrum disordersMatern Child Health J201418367268023793533
   PubMed Web of Science ®Google Scholar
• LakeJKVoganVSawyerAWeissJALunskyYPsychotropic medication use among adolescents and young adults with an autism spectrum disorder: parent views about medication use and healthcare servicesJ Child Adolesc Psychopharmacol201525326026825803636
   PubMed Web of Science ®Google Scholar
• DoughertyMJWicklundCJohansen TaberKAChallenges and opportunities for genomics education: insights from an Institute of Medicine roundtable activityJ Contin Educ Health Prof2016361828526954250
   PubMed Web of Science ®Google Scholar
• De LeonJArmstrongSCCozzaKLClinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19Psychosomatics2006471758516384813
   PubMed Web of Science ®Google Scholar
• Hall-FlavinDKWinnerJGAllenJDUtility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient settingPharmacogenet Genomics2013231053554824018772
   PubMed Web of Science ®Google Scholar